Total Payments
$206,117
2024 Payments
$11,835
Companies
60
Transactions
917
Medicare Patients
1,743
Medicare Billing
$202,121
Payment Breakdown by Category
Other$164,463 (79.8%)
Food & Beverage$18,058 (8.8%)
Consulting$14,958 (7.3%)
Travel$8,520 (4.1%)
Education$118.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $164,419 | 110 | 79.8% |
| Food and Beverage | $18,058 | 750 | 8.8% |
| Consulting Fee | $14,958 | 7 | 7.3% |
| Travel and Lodging | $8,520 | 47 | 4.1% |
| Education | $118.25 | 2 | 0.1% |
| Grant | $43.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $80,939 | 166 | $0 (2024) |
| Lilly USA, LLC | $66,720 | 172 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $17,613 | 45 | $0 (2022) |
| Allergan, Inc. | $13,377 | 64 | $0 (2021) |
| ABBVIE INC. | $10,495 | 84 | $0 (2024) |
| PFIZER INC. | $8,869 | 22 | $0 (2024) |
| Amgen Inc. | $930.34 | 38 | $0 (2024) |
| UCB, Inc. | $734.14 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $586.42 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $572.24 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,835 | 138 | PFIZER INC. ($8,827) |
| 2023 | $2,234 | 105 | UCB, Inc. ($338.36) |
| 2022 | $32,490 | 115 | Biohaven Pharmaceutical Holding Company Ltd. ($17,613) |
| 2021 | $24,310 | 117 | Lilly USA, LLC ($8,414) |
| 2020 | $78,515 | 186 | Teva Pharmaceuticals USA, Inc. ($37,807) |
| 2019 | $42,450 | 156 | Teva Pharmaceuticals USA, Inc. ($25,025) |
| 2018 | $13,684 | 87 | Teva Pharmaceuticals USA, Inc. ($11,200) |
| 2017 | $599.64 | 13 | Avanir Pharmaceuticals, Inc. ($241.09) |
All Payment Transactions
917 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Neurology | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: PAIN | ||||||
| 12/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | PFIZER INC. | ZAVZPRET (Drug) | Travel and Lodging | In-kind items and services | $505.40 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Neurology | ||||||
| 11/20/2024 | PFIZER INC. | ZAVZPRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: PAIN | ||||||
| 11/19/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $83.38 | General |
| Category: PAIN | ||||||
| 11/16/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Eli Lilly and Company | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $87.47 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $39.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Neurology | ||||||
| 11/06/2024 | PFIZER INC. | ZAVZPRET (Drug) | Travel and Lodging | In-kind items and services | $29.44 | General |
| Category: PAIN | ||||||
| 11/06/2024 | PFIZER INC. | ZAVZPRET (Drug) | Travel and Lodging | In-kind items and services | $19.96 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neurology | ||||||
| 10/31/2024 | PFIZER INC. | ZAVZPRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 452 | 8,921 | $206,023 | $86,344 |
| 2022 | 9 | 397 | 492 | $113,607 | $35,302 |
| 2021 | 8 | 441 | 580 | $129,820 | $43,670 |
| 2020 | 9 | 453 | 588 | $108,414 | $36,805 |
Total Patients
1,743
Total Services
10,581
Medicare Billing
$202,121
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 8,300 | $62,333 | $39,902 | 64.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 169 | $39,884 | $14,320 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 72 | 72 | $32,400 | $11,381 | 35.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 78 | 133 | $29,792 | $6,298 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 41 | $12,956 | $5,099 | 39.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 37 | $11,100 | $3,912 | 35.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 70 | 84 | $4,851 | $2,347 | 48.4% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 28 | 46 | $7,498 | $2,107 | 28.1% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 27 | 27 | $4,050 | $682.56 | 16.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 12 | $1,159 | $295.08 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 160 | $37,760 | $13,138 | 34.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $27,450 | $8,761 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 40 | $12,640 | $4,994 | 39.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 61 | 76 | $17,024 | $3,213 | 18.9% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 26 | 40 | $6,520 | $1,817 | 27.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 53 | 53 | $3,061 | $1,423 | 46.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 12 | $2,400 | $838.97 | 35.0% |
| 92081 | Exam of visual field with limited testing | Office | 2022 | 36 | 36 | $5,400 | $813.82 | 15.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 12 | 14 | $1,352 | $303.86 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 148 | $34,928 | $13,399 | 38.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 66 | 66 | $29,700 | $10,447 | 35.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 50 | 55 | $17,380 | $7,269 | 41.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 80 | 118 | $26,432 | $5,574 | 21.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 76 | 97 | $5,602 | $2,720 | 48.6% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 34 | 56 | $9,128 | $2,620 | 28.7% |
About Dr. Stacy Smith, M.D
Dr. Stacy Smith, M.D is a Neurology healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1306138235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacy Smith, M.D has received a total of $206,117 in payments from pharmaceutical and medical device companies, with $11,835 received in 2024. These payments were reported across 917 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($164,419).
As a Medicare-enrolled provider, Smith has provided services to 1,743 Medicare beneficiaries, totaling 10,581 services with total Medicare billing of $202,121. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neuro-ophthalmology
- Location Bellaire, TX
- Active Since 05/11/2011
- Last Updated 08/19/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1306138235
Products in Payments
- AJOVY (Biological) $44,496
- AJOVY (Drug) $35,861
- EMGALITY (Drug) $34,734
- UBRELVY (Drug) $21,892
- REYVOW (Drug) $20,900
- NURTEC ODT (Drug) $18,343
- ZAVZPRET (Drug) $8,578
- BOTOX (Biological) $989.98
- VRAYLAR (Drug) $529.30
- ANDEXXA (Biological) $503.51
- Aimovig (Biological) $415.87
- AIMOVIG (Biological) $365.32
- INGREZZA (Drug) $343.55
- Briviact (Drug) $331.77
- QULIPTA (Drug) $260.53
- Fycompa (Drug) $253.54
- Leqembi (Drug) $246.75
- UPLIZNA (Biological) $225.60
- KESIMPTA (Drug) $209.69
- Gamunex-C (Biological) $202.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bellaire
Dr. Brian Loftus, M.d, M.D
Neurology — Payments: $254,736
Neurology $254,736
Dr. Mary Vanderlick, Md, MD
Neurology — Payments: $43,533
Neurology $43,533
Dr. William Irr, Md, MD
Neurology — Payments: $35,337
Neurology $35,337
Dr. Danny Chachere, M.d, M.D
Neurology — Payments: $21,175
Neurology $21,175
Dr. Sonia Krish, M.d, M.D
Neurology — Payments: $185.27
Neurology $185.27
Maureen Handoko-Yang, Md, Phd, MD, PHD
Neurology — Payments: $93.41
Neurology $93.41